Ternansky R J, Draheim S E, Pike A J, Counter F T, Eudaly J A, Kasher J S
Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana 46285.
J Med Chem. 1993 Oct 29;36(22):3224-9. doi: 10.1021/jm00074a002.
The structure-activity relationship among a series of novel pyrazolidinone antibacterial agents is described. Specifically, the effect of modification of the side chain attached to the nitrogen at C-7 was explored in an attempt to improve the potency and spectrum of activity. This approach was successful in identifying several compounds having good in vitro profiles. These top candidates were then evaluated for their activity in vivo, and their pharmacokinetic behavior in various animal models was explored. This information proved critical for the identification of candidates for clinical evaluation.
